Nathan Day

Nathan Day currently serves as Associate Director of Global Value & Access Strategy in Oncology and previously as Associate Director of US Pricing and Access at Gilead Sciences since June 2020. Prior roles include Senior Manager of US Pricing and Access, leading initiatives for Inflammation, COVID, HBV, HCV, and HDV, and consulting on pricing and market access strategies at Jupiter Life Science Consulting. Nathan also served as an Officer in the US Navy and worked as an Associate Consultant at IQVIA and a Business Associate at ZS Associates, along with a role as a Visiting Research Associate at UCSF. Nathan holds a degree in Biology from Vanderbilt University.